OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

CRH PLC (DI)/  IE0001827041  /

Turquoise
2024-05-31  5:29:55 PM Chg. -114.00 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
6,104.00GBX -1.83% 570,741
Turnover(GBP): 35.27 mill.		 -Bid Size: - -Ask Size: - 46.45 bill.GBP - -
GlobeNewswire 05-06 ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire 04-30 Martin Marietta Reports First-Quarter 2024 Results
GlobeNewswire 04-09 Emerging Markets Report: Follow the Leader
GlobeNewswire 03-28 Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
GlobeNewswire 03-26 Aptose Reports Results for the Fourth Quarter and Full Year 2023
GlobeNewswire 03-14 HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI...
GlobeNewswire 02-27 Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-26 ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
GlobeNewswire 02-12 Martin Marietta Announces Acquisition of Aggregates Operations From Affiliates of Blue Water Industr...
GlobeNewswire 01-30 Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
GlobeNewswire 2023-12-18 Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
GlobeNewswire 2023-12-11 Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (lu...
GlobeNewswire 2023-12-11 Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib ...
GlobeNewswire 2023-11-21 Martin Marietta to Divest South Texas Cement and Related Concrete Operations to CRH plc
GlobeNewswire 2023-11-14 Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-11-09 Aptose Reports Results for the Third Quarter 2023
GlobeNewswire 2023-11-02 Kura Oncology Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-30 Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug ...
GlobeNewswire 2023-10-27 ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023
GlobeNewswire 2023-10-23 Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
GlobeNewswire 2023-10-16 Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th Int...
TeleTrader 2023-10-12 Europe opens higher amid economic data, US inflation report
GlobeNewswire 2023-09-18 Aptose to Present at the Cantor Global Healthcare Conference
GlobeNewswire 2023-09-11 Media Advisory: Gary White and Matt Damon to join CEOs and global leaders at UN Global Compact Leade...
Newsfile Corp 2023-08-29 Teako Minerals Announces Changes to Board of Directors